Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2CNS 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 5Breast Neoplasms 4Small Cell Lung Carcinoma 3Pancreatic Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Melanoma 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Liver Neoplasms 1Kidney Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Surveys and Questionnaires 5Nivolumab 5pembrolizumab 3atezolizumab 3Radiosurgery 3pralsetinib 2pertuzumab 2cobimetinib 2cemiplimab 2amminedichloro(2-methylpyridine)platinum(II) 2alectinib 2Magnetic Resonance Spectroscopy 2Exercise 2Drug Therapy 2trastuzumab deruxtecan 1trametinib 1tepotinib 1talazoparib 1selpercatinib 1repotrectinib 1remune 1ponatinib 1pemigatinib 1pazopanib 1palbociclib 1osimertinib 1motexafin gadolinium 1montanide ISA 51 1itacitinib 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × pazopanib × Thoracic × Clear all
NCT01392352 2020-02-13

HYPAZ

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated
31 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡